Melissa Johnson

10PUBLICATIONS
33CO-AUTHORS
Toxicology (incl. clinical toxicology)Intensive careApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Planning and decision makingRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 19, 2025
Co-administration of triazoles with calcineurin or mammalian target of rapamycin inhibitors in solid organ transplant patients hospitalized with invasive aspergillosis.

Barbara Alexander, Melissa D Johnson, Belinda Lovelace

|Oct 13, 2025
Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy.

April Dyer, Elizabeth Dodds-Ashley, Angelina Davis

|Sep 26, 2025
Healthcare Resource Utilization, Treatment Costs, and Mortality in Patients with Malignancies or Transplantation Who Develop Invasive Aspergillosis.

Thomas J Walsh, Craig I Coleman, Melissa Johnson

|Jan 20, 2025
Association Between the Need to Change Initial Antifungal Therapy and Treatment Costs in Patients With Invasive Aspergillosis.

Barbara D Alexander, Melissa Johnson, Mark Bresnik

|Jun 10, 2024
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy: An executive summary.

David B Cluck, Daniel B Chastain, Milena Murray

|Jun 10, 2024
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment-experienced and/or have multidrug-resistant HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy.

David B Cluck, Daniel B Chastain, Milena Murray

Pageof 2

Frequent Collaborators

4 joint publications

Barbara D Alexander

3 joint publications

Craig I Coleman

2 joint publications

Deverick J Anderson

2 joint publications

Spencer H Durham